US3607869A - Process for hydrolyzing 7-aminocephalosporanic acid lactone - Google Patents

Process for hydrolyzing 7-aminocephalosporanic acid lactone Download PDF

Info

Publication number
US3607869A
US3607869A US877481A US3607869DA US3607869A US 3607869 A US3607869 A US 3607869A US 877481 A US877481 A US 877481A US 3607869D A US3607869D A US 3607869DA US 3607869 A US3607869 A US 3607869A
Authority
US
United States
Prior art keywords
lactone
aminocephalosporanic acid
desacetyl
seconds
hydrolyzing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US877481A
Other languages
English (en)
Inventor
Constantino John Di Cuollo
George L Dunn
Louis R Fare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
SmithKline Beecham Corp
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of US3607869A publication Critical patent/US3607869A/en
Assigned to SMITHKLINE BECKMAN CORPORATION reassignment SMITHKLINE BECKMAN CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). EFFECTIVE DATE: 03/04/82 Assignors: SMITHKLINE CORPORATION
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents

Definitions

  • Desacetyl 7-aminocephalosporanic acid is obtained chemically in reasonable yield from desacetyl 7- aminocephalosporanic acid lactone by subjecting the lactone in a basic water-containing medium to a pH of ll-l3 for 5 seconds to 5' minutes.
  • the amino group of alcohol I can be acylated by known' methods with any of a number of known-acylating agents to produce desacetyl cephalosporins; which are antibiotic agents.
  • the lactone II is also a known compound (U.S. Pat. No. 3,207,755); but there has heretofore been no means for con-. verting the lactone to the useful alcohol 1.
  • the alcohol product has thus not up to this time been obtainable from the lactone chemically in yields high enough to be adaptable to commercial production.
  • the alcohol has been obtainable only by enzymatic hydrolysis of the acetoxy group of a compound such as 7-aminocephalosporanic acid.
  • the present invention therefore, has as its principal object the provision of a method of chemically hydrolyzing the lactone of desacetyl 7-aminocephalosporanic acid (11) to desacetyl 7-aminocephalosporanic acid (I) in yields high enough to offer promise of commercial feasibility.
  • the availability of the lactone 11 by total synthesis (French Pats. Nos.
  • the process of the present invention generally consists of subjecting the lactone 11, or a salt thereof, to a water-containing basic medium of pH 11-13 for about seconds to 5 minutes.
  • the critical variables are the time and the pH. Use of longer periods of times will result in ring-opening of the B-lactam in addition to the lactone ring.
  • some lactam ring-opening does occur, limitation of the time as stated above enables one to obtain a sufficient amount of the desired product in which the lactam ring is v intact, while the lactone ring has been hydrolyzed.
  • the pH is i also a critical factor, since below pH 1 l, lactam-opening is extensive with little lactone-opening, and above pH 13, extensive secondary decomposition occurs.
  • the preferred conditions are pH 11.5-12.5 for 5-60 seconds.
  • the temperature of the reaction when conducted at pH 11-13 for 5 seconds to 5 minutes should be approximately room temperature (20-30 C., preferably 25-27 C. Variation between 0-l00 C. is possible, but the optimal pH and time of reaction will be shifted.
  • the solvent for the reaction is not critical, provided it contains some water for hydrolysis and provided also that it dissolves the starting material.
  • aqueous alcohols, acetone, dimethylformamide, or tetrahydrofuran are satisfactory.
  • the reaction is most preferably conducted by dissolving a salt (including the hydrochloride, acetate, sulfate, etc.) of the lactone in water, quickly adjusting the pH to about 12 with aqueous base, and 15-30 seconds later, adding acid to pH 7 to terminate the reaction.
  • a salt including the hydrochloride, acetate, sulfate, etc.
  • the desired pH for the hydrolysis reaction is attained by use of such conventional basic materials as hydroxides, including sodium or potassium hydroxide; quaternary ammonium hydroxides, including ion exchange resins; and buffers capable of maintaining the desired pH.
  • the alcohol product may be isolated by any convenient method, since the invention resides in the particular hydrolytic conditions, rather than in any manner of isolation.
  • a preferred method of isolation consists of lyophilizing a mixture of the reaction solution and cellulose and then chromatographing this material on a cellulose column at 5 C., percent acetronitrile in water being the eluant. Starting material, if any remains, will be eluted first, any lactam ringopened byproductnext, and the desired hydroxy acid last.
  • the product can be isolated by ion exchange chromatography. Evaporation of solvent under'reduced pressure gives. the crude product, which can be further purified by conventional means.
  • EXAMPLE 2 The procedure in example 2 is the same as that described in example 1, except that the pH is adjusted to 1 1.0 and the reaction is allowed to proceed for 5 minutes. When desacetyl 7- aminocephalosporanic acid was estimated by bioassay, the conversion was approximately 10 percent.
  • EXAMPLE 3 The procedure in example 3 is the same as that described in example 1, except that the pH is adjusted to 1 1.5 and the reaction is allowed to proceed for 15-30 seconds. When desacetyl 7-aminocephalosporanic acid was estimated by bioassay, the conversion was approximately 15 percent.
  • EXAMPLE 4 The procedure is example 4 is the same as that described in example 1, except that the pH is adjusted to 13.0 and the reaction is allowed to proceed for 5-10 seconds.
  • desacetyl 7-aminocephalosporanic acid was estimated by bioassay, the
  • a process for hydrolyzing desacetyl 7- aminocephalosporanic acid lactone to desacetyl 7- aminocephalosporanic acid comprising subjecting the said lactone in a water-containing medium to a pH of 1 1-13 for 5 seconds to 5 minutes.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
US877481A 1969-11-17 1969-11-17 Process for hydrolyzing 7-aminocephalosporanic acid lactone Expired - Lifetime US3607869A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87748169A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
US3607869A true US3607869A (en) 1971-09-21

Family

ID=25370056

Family Applications (1)

Application Number Title Priority Date Filing Date
US877481A Expired - Lifetime US3607869A (en) 1969-11-17 1969-11-17 Process for hydrolyzing 7-aminocephalosporanic acid lactone

Country Status (11)

Country Link
US (1) US3607869A (nl)
JP (1) JPS4932550B1 (nl)
BE (1) BE757176A (nl)
CA (1) CA918656A (nl)
CH (1) CH534181A (nl)
DE (1) DE2055336A1 (nl)
FR (1) FR2067328B1 (nl)
GB (1) GB1276413A (nl)
LU (1) LU62058A1 (nl)
NL (1) NL7015871A (nl)
ZA (1) ZA706510B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864338A (en) * 1970-08-11 1975-02-04 Squibb & Sons Inc Process for the preparation of {66 {hu 2{b -cephalosporin aldehydes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864338A (en) * 1970-08-11 1975-02-04 Squibb & Sons Inc Process for the preparation of {66 {hu 2{b -cephalosporin aldehydes

Also Published As

Publication number Publication date
NL7015871A (nl) 1971-05-19
ZA706510B (en) 1971-05-27
BE757176A (fr) 1971-04-07
FR2067328A1 (nl) 1971-08-20
JPS4932550B1 (nl) 1974-08-31
GB1276413A (en) 1972-06-01
LU62058A1 (nl) 1971-05-11
CA918656A (en) 1973-01-09
DE2055336A1 (de) 1971-05-27
CH534181A (de) 1973-02-28
FR2067328B1 (nl) 1973-02-02

Similar Documents

Publication Publication Date Title
Hughes Progress in the Mitsunobu reaction. A review
US3124576A (en) Hjn-ch-ch
US3868360A (en) Process for preparing 2-deroxy-3-desamino-2,3-epimino-aminoglycosides and intermediates useful therein
US3607869A (en) Process for hydrolyzing 7-aminocephalosporanic acid lactone
Handa et al. The pyranoside ring as a nucleophile in aldol condensations
US3632607A (en) Process for purifying kalafungin
US2390499A (en) Preparation of calcium pantothenate
EP0517345B1 (en) Intermediates of the mureidomycin group, their preparation, and their use
Kuzuhara et al. Stereoselective synthesis of 5-O-carbamoylpolyoxamic acid (2-amino-5-O-carbamoyl-2-deoxy-l-xylonic acid
US4159990A (en) Reduction of 2,5-diketogluconic acid
Barili et al. Alkaline and enzymatic hydrolysis of isobutyl 3, 4-anhydro-2, 6-dideoxy-DL-hexopyranosides. Preparation of enantiomeric boivinopyranosides through a highly efficient kinetic resolution
US3676437A (en) Recovery of pure cephalexin
US2358337A (en) Vitamin intermediates and their preparation
Wakamiya et al. Chemical studies on tuberactinomycin. V. Structures of guanidino amino acids in tuberactinomycins
Kuzuhara et al. Preparation of perbenzylated 2-azido-2-deoxy-D-allono-1, 5-lactone and its condensation with an amino acid ester
US4845246A (en) Ascorbic acid ester
US3714199A (en) Methylene dioxyamine
US4242503A (en) Process for O-demethylating fortimicins
KR860001369B1 (ko) 페니실란산 에스테르류의 제조 방법
US3627824A (en) Process for crystallizing{65 -alkylmercaptolysine dihydrochloride
IE35480L (en) 3 : 4 -dideoxykanamycin b
US4446069A (en) Process for the preparation of β-lactam antibiotics
US3113134A (en) Process for the production of reserpic acid diesters
SU504494A3 (ru) Способ получени сердечных гликозидов
US4337350A (en) Reduction of 2,5-diketogluconic acid

Legal Events

Date Code Title Description
AS Assignment

Owner name: SMITHKLINE BECKMAN CORPORATION, PENNSYLVANIA

Free format text: CHANGE OF NAME;ASSIGNOR:SMITHKLINE CORPORATION;REEL/FRAME:004080/0769

Effective date: 19820304

Owner name: SMITHKLINE BECKMAN CORPORATION

Free format text: CHANGE OF NAME;ASSIGNOR:SMITHKLINE CORPORATION;REEL/FRAME:004080/0769

Effective date: 19820304